Estimating unmet transplant need sits at the center of equitable transplant planning
Accurate measurement of unmet transplant need is not a statistical exercise for health systems committees alone. It determines who gets referred, who waits, who is counted, and which communities remain outside the reach of curative or life-extending care. In an authors’ reply published in The Lancet Oncology, the central claim is direct: planning equitable transplantation services depends on estimating need correctly, rather than relying on partial demand signals or the number of patients already visible to specialist centers.
The distinction has real clinical consequences. If policy makers anchor service design only to people already listed or already known to transplant programs, they will systematically undercount patients who never reach assessment, never complete workup, or are never identified as candidates in the first place. In transplant medicine, the numerator is often easier to see than the denominator. The more invisible the unmet need, the more easily shortages can be mistaken for stable demand.
A single sentence captures the practical burden.
If unmet need is underestimated, inequity becomes embedded in the referral pathway before a patient ever reaches a transplant table.
Why transplant planning depends on the denominator, not just the queue
Transplant services are built on constrained capacity: donor availability, surgical expertise, immunologic matching, perioperative infrastructure, longitudinal follow-up, and the systems required to support candidates before and after transplantation. When planners do not know the full size of the eligible or potentially eligible population, they cannot model capacity realistically. The result is familiar in many health systems: waitlists that reflect access to evaluation rather than access to treatment, and service maps that mirror geography and specialty distribution more than clinical need.
The title of the reply points to an argument that is both methodological and ethical. Estimating unmet need requires more than counting procedures performed. It requires asking how many patients could benefit, how many are medically eligible, how many are excluded by late presentation or comorbidity, and how many are never captured by existing registry pathways. Each of those steps can distort service planning if treated as a fixed boundary instead of a moving target.
For oncology-associated transplantation questions, this issue becomes even more sensitive. Cancer care and transplantation intersect across highly selected populations, where timing, tumor biology, performance status, and treatment history shape candidacy. Small errors in estimating need can cascade into larger disparities because access depends on coordinated decisions across multiple specialties. When a service is designed around incomplete data, it may appear efficient while still missing the patients most likely to be excluded by structural barriers.
Equity starts with counting patients who are not yet visible
Equitable transplantation services cannot be planned from lists alone. Patients who are not referred, not diagnosed in time, not offered assessment, or not able to travel to a transplant center remain outside the administrative records that often drive policy. That gap matters because access is not determined only by biology. It is also determined by diagnostics, referral patterns, social support, language, insurance status, and the concentration of transplant expertise in a limited number of centers.
A more accurate estimate of unmet need helps health systems answer basic service questions: How many transplant evaluations are required annually? Where should multidisciplinary clinics be located? How much perioperative capacity is needed? Which populations are most likely to fall through the cracks? Without those answers, a transplant program may expand in name while remaining inaccessible in practice.
The concept also has implications for fairness in allocation debates. If need is underestimated, scarcity appears more severe than it is in one group and less severe than it is in another. Resource planning then becomes reactive rather than preventive. That is especially problematic in transplantation, where delays can permanently alter candidacy and where disease progression can close the window for referral altogether.
Methodology shapes policy, and policy shapes access
The title of the reply suggests a broader disagreement about how unmet need should be measured and interpreted. In transplantation, methodology is not an academic footnote. Different case definitions, registry sources, eligibility assumptions, and population denominators can produce very different estimates of need. A narrow model may be useful for operational planning inside a single center, while a broader model may be necessary for regional or national equity planning. Both can be informative, but they answer different questions.
That is why accurate estimation matters so much. Health systems may use a single estimate to justify workforce expansion, donor infrastructure, outreach programs, or referral pathway redesign. If the estimate is too low, policy will underbuild capacity. If it is too high without careful clinical filtering, resources may be allocated inefficiently. The challenge is to build estimates that reflect real-world clinical eligibility while still capturing hidden unmet demand.
In practical terms, transplant planning should not stop at counting procedures performed in the previous year. It should incorporate the patients who were referred too late, those who were never referred, and those whose candidacy was lost before a transplant decision could even be made. That broader view is the only way to match service capacity to need rather than to historical access patterns.
A planning problem with bedside consequences
Behind every estimate is a patient whose care pathway can stall for administrative reasons long before organ availability becomes the limiting step. Transplant systems that underestimate need are likely to ration access implicitly, not explicitly. They may do so through long assessment queues, limited outreach, sparse geographic coverage, or inadequate downstream follow-up. Those constraints are not neutral; they distribute opportunity unevenly.
For clinicians, the message is straightforward. Referrals, registry counts, and completed transplants do not fully describe demand for care. For health planners, the obligation is equally direct: measure the unmet need carefully enough to expose hidden inequity, then design services that can absorb that burden. The reply’s core argument leaves little room for complacency. Until unmet transplant need is counted accurately, equity in transplantation will remain a goal shaped more by inference than by evidence.